Constitutive activation of c-KIT, associated with various mutation profiles, is observed in the majority of GISTs.
(2014) recently described c-Kit levels as a robust marker of HSCs, with intermediate levels of c-Kit associating with durable self-renewal potential.
Imatinib is a small molecule inhibitor of KIT that inhibits proliferation and induces apoptosis in melanoma cells harbouring KIT mutations, associated with significant clinical response in these patients [46].
Endothelial cell expression of phosphorylated KIT was associated with endothelial cell SCF expression (P = 0.0002), but neither endothelial cell phosphorylated KIT nor SCF expression was associated with endothelial cell VEGFR-2 expression (P = 0.62 and 0.57, respectively).
Recently, the occurrence of KIT epigenetic silencing in cutaneous melanomas has been demonstrated [ 25], supporting earlier studies that had shown decrease of KIT expression associated with melanoma progression [ 26].
Gain-of-function mutations in KIT are associated with mastocytosis, GIST, and various human neoplasms [6].
The activation of KIT is associated with tumor proliferation, differentiation, adhesion, and apoptosis [ 13].
Likewise, "Made a survival kit" was associated with social well-being (r = .13).13
Mutations in KIT are associated with the chromosomal translocation t(8 21) and inv(16) and are prognostic unfavorable parameters in this subgroup of AML [ 34, 35].
BRAF-mutated tumors tend to occur on skin subject to high intermittent sun exposure, whereas mutations in the tyrosine kinase receptor KIT are associated with melanomas from acral and mucosal sites.
Future use of a PSA self test kit was associated with, male gender (p < 0.001), younger age (p < 0.001) and IMD quartile (p < 0.05), with men resident in IMD quartiles 1 and 2 (less deprived) being more likely to report possible future use.
